Which oral muscle relaxant is appropriate for an elderly patient in their late 80s with an estimated glomerular filtration rate of 72 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tizanidine is the Preferred Muscle Relaxant for Patients in Their Late 80s with GFR 72

For an elderly patient in their late 80s with a GFR of 72 mL/min, tizanidine is the most appropriate oral muscle relaxant choice, as traditional "muscle relaxants" like cyclobenzaprine, methocarbamol, and carisoprodol should be avoided in older adults due to lack of efficacy evidence in chronic conditions and significant adverse effect risks.

Why Tizanidine is Preferred

The 2020 JAGS guideline explicitly states that so-called muscle relaxants including methocarbamol, carisoprodol, chlorzoxazone, metaxalone, and cyclobenzaprine "do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain" and are "not favored for chronic pain" in older adults due to potential adverse effects 1.

Tizanidine stands apart as it is classified as a GABA-B agonist and alpha-2 adrenergic agonist with actual muscle relaxant properties, unlike the traditional agents which are primarily sedating antihistamines or anticholinergics 1.

Renal Considerations at GFR 72

With a GFR of 72 mL/min, this patient has Stage 2 CKD (mild reduction in kidney function). While the 2009 consensus guidelines focused on medications requiring dose adjustment below GFR 60 2, tizanidine does not require dose adjustment at this level of renal function. However, caution is still warranted given the patient's advanced age.

Comparative Safety Profile

Recent 2024 data demonstrates important safety distinctions:

  • Baclofen carries a significantly higher fall risk compared to tizanidine in older adults (subdistribution hazard ratio 1.68,95% CI 1.20-2.36) 3
  • Cyclobenzaprine showed comparable fall risk to baclofen but has a more significant adverse event profile including CNS sedation 3, 4
  • Tizanidine demonstrated the lowest fall risk among muscle relaxants studied 3

Dosing Strategy for Tizanidine

Start with 2 mg at bedtime and titrate slowly:

  • Initial: 2 mg once daily (preferably at bedtime)
  • Titration: Increase by 2-4 mg every 3-7 days as tolerated
  • Target: Usually 6-12 mg daily in divided doses (maximum 36 mg/day, though elderly rarely need this)
  • Monitor blood pressure closely as hypotension is the primary dose-limiting side effect

Critical Caveats

Avoid these agents entirely in this population:

  • Cyclobenzaprine, methocarbamol, carisoprodol, metaxalone: No evidence of efficacy, high sedation risk 1
  • Baclofen: Higher fall risk than alternatives 3
  • Diazepam: Addiction potential and CNS depression 4

If tizanidine is not tolerated, consider non-pharmacologic approaches first before attempting another muscle relaxant, as the evidence strongly suggests this entire drug class is problematic in the very elderly 1.

References

Guideline

a practical approach to using adjuvant analgesics in older adults.

Journal of the American Geriatrics Society (JAGS), 2020

Guideline

consensus guidelines for oral dosing of primarily renally cleared medications in older adults.

Journal of the American Geriatrics Society (JAGS), 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.